Founded in March 2020, BioTimes, Inc. is a US-based biotechnology company with a focus on developing and manufacturing affordable, high-quality research reagents and IVD raw materials, including bioactive recombinant proteins, validated antibodies, and in vitro use immunoassay products. We aim to provide highest value and outstanding services to biomedical researchers and diagnostic companies around the world, to enable their discovery and product innovation. BioTimes, Inc. is committed to provide high-quality immunoassays, bio-functional recombinant proteins and highly validated antibody reagents for research communities and for in vitro diagnostic companies around the world.